Purine metabolism, Xanthine phosphoribosyltransferase XRPT
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | yes | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 13 |
NetGPI | no | yes: 0, no: 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 4 |
GO:0005777 | peroxisome | 6 | 1 |
GO:0005829 | cytosol | 2 | 1 |
GO:0020015 | glycosome | 7 | 1 |
GO:0020022 | acidocalcisome | 5 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0042579 | microbody | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 4 |
GO:0006144 | purine nucleobase metabolic process | 5 | 1 |
GO:0006163 | purine nucleotide metabolic process | 5 | 4 |
GO:0006164 | purine nucleotide biosynthetic process | 6 | 4 |
GO:0006177 | GMP biosynthetic process | 8 | 1 |
GO:0006178 | guanine salvage | 6 | 1 |
GO:0006188 | IMP biosynthetic process | 8 | 4 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 4 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 4 |
GO:0006793 | phosphorus metabolic process | 3 | 4 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 4 |
GO:0006807 | nitrogen compound metabolic process | 2 | 4 |
GO:0008152 | metabolic process | 1 | 4 |
GO:0009058 | biosynthetic process | 2 | 4 |
GO:0009112 | nucleobase metabolic process | 4 | 1 |
GO:0009113 | purine nucleobase biosynthetic process | 6 | 1 |
GO:0009117 | nucleotide metabolic process | 5 | 4 |
GO:0009123 | nucleoside monophosphate metabolic process | 5 | 4 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 6 | 4 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 6 | 4 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 7 | 4 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 4 |
GO:0009152 | purine ribonucleotide biosynthetic process | 7 | 4 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 7 | 4 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 6 | 4 |
GO:0009165 | nucleotide biosynthetic process | 6 | 4 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 7 | 4 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 8 | 4 |
GO:0009259 | ribonucleotide metabolic process | 5 | 4 |
GO:0009260 | ribonucleotide biosynthetic process | 6 | 4 |
GO:0009987 | cellular process | 1 | 4 |
GO:0018130 | heterocycle biosynthetic process | 4 | 4 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 4 |
GO:0019637 | organophosphate metabolic process | 3 | 4 |
GO:0019693 | ribose phosphate metabolic process | 4 | 4 |
GO:0032261 | purine nucleotide salvage | 5 | 4 |
GO:0032263 | GMP salvage | 7 | 1 |
GO:0032264 | IMP salvage | 7 | 4 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 4 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 4 |
GO:0043094 | cellular metabolic compound salvage | 3 | 4 |
GO:0043096 | purine nucleobase salvage | 5 | 1 |
GO:0043101 | purine-containing compound salvage | 4 | 4 |
GO:0043173 | nucleotide salvage | 4 | 4 |
GO:0044237 | cellular metabolic process | 2 | 4 |
GO:0044238 | primary metabolic process | 2 | 4 |
GO:0044249 | cellular biosynthetic process | 3 | 4 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 4 |
GO:0044281 | small molecule metabolic process | 2 | 4 |
GO:0046037 | GMP metabolic process | 7 | 1 |
GO:0046040 | IMP metabolic process | 7 | 4 |
GO:0046098 | guanine metabolic process | 6 | 1 |
GO:0046099 | guanine biosynthetic process | 7 | 1 |
GO:0046100 | hypoxanthine metabolic process | 6 | 1 |
GO:0046112 | nucleobase biosynthetic process | 5 | 1 |
GO:0046390 | ribose phosphate biosynthetic process | 5 | 4 |
GO:0046483 | heterocycle metabolic process | 3 | 4 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 4 |
GO:0071704 | organic substance metabolic process | 2 | 4 |
GO:0072521 | purine-containing compound metabolic process | 4 | 4 |
GO:0072522 | purine-containing compound biosynthetic process | 5 | 4 |
GO:0090407 | organophosphate biosynthetic process | 4 | 4 |
GO:0106380 | purine ribonucleotide salvage | 6 | 4 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 4 |
GO:1901137 | carbohydrate derivative biosynthetic process | 4 | 4 |
GO:1901293 | nucleoside phosphate biosynthetic process | 5 | 4 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 4 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 4 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 4 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 4 |
GO:1901576 | organic substance biosynthetic process | 3 | 4 |
GO:0006166 | purine ribonucleoside salvage | 5 | 3 |
GO:0009116 | nucleoside metabolic process | 4 | 3 |
GO:0009119 | ribonucleoside metabolic process | 5 | 3 |
GO:0009163 | nucleoside biosynthetic process | 5 | 3 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 4 | 3 |
GO:0042278 | purine nucleoside metabolic process | 5 | 3 |
GO:0042451 | purine nucleoside biosynthetic process | 6 | 3 |
GO:0042455 | ribonucleoside biosynthetic process | 6 | 3 |
GO:0043174 | nucleoside salvage | 4 | 3 |
GO:0044283 | small molecule biosynthetic process | 3 | 3 |
GO:0046128 | purine ribonucleoside metabolic process | 6 | 3 |
GO:0046129 | purine ribonucleoside biosynthetic process | 7 | 3 |
GO:1901657 | glycosyl compound metabolic process | 4 | 3 |
GO:1901659 | glycosyl compound biosynthetic process | 5 | 3 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 14 |
GO:0004422 | hypoxanthine phosphoribosyltransferase activity | 6 | 8 |
GO:0016740 | transferase activity | 2 | 14 |
GO:0016757 | glycosyltransferase activity | 3 | 14 |
GO:0016763 | pentosyltransferase activity | 4 | 8 |
GO:0052657 | guanine phosphoribosyltransferase activity | 6 | 8 |
GO:0106130 | purine phosphoribosyltransferase activity | 5 | 8 |
GO:0000287 | magnesium ion binding | 5 | 1 |
GO:0000310 | xanthine phosphoribosyltransferase activity | 6 | 3 |
GO:0005488 | binding | 1 | 4 |
GO:0043167 | ion binding | 2 | 4 |
GO:0043169 | cation binding | 3 | 4 |
GO:0046872 | metal ion binding | 4 | 4 |
GO:0000166 | nucleotide binding | 3 | 3 |
GO:0036094 | small molecule binding | 2 | 3 |
GO:0097159 | organic cyclic compound binding | 2 | 3 |
GO:1901265 | nucleoside phosphate binding | 3 | 3 |
GO:1901363 | heterocyclic compound binding | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 56 | 60 | PF00656 | 0.319 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.218 |
CLV_PCSK_SKI1_1 | 147 | 151 | PF00082 | 0.237 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.363 |
DOC_ANK_TNKS_1 | 15 | 22 | PF00023 | 0.380 |
DOC_MAPK_gen_1 | 145 | 152 | PF00069 | 0.422 |
DOC_MAPK_gen_1 | 176 | 184 | PF00069 | 0.492 |
DOC_MAPK_gen_1 | 219 | 228 | PF00069 | 0.354 |
DOC_PP1_RVXF_1 | 158 | 165 | PF00149 | 0.515 |
DOC_PP1_RVXF_1 | 189 | 196 | PF00149 | 0.460 |
DOC_PP2B_PxIxI_1 | 84 | 90 | PF00149 | 0.429 |
DOC_USP7_MATH_1 | 25 | 29 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.344 |
DOC_USP7_UBL2_3 | 172 | 176 | PF12436 | 0.515 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.582 |
LIG_14-3-3_CanoR_1 | 119 | 124 | PF00244 | 0.406 |
LIG_BIR_III_4 | 12 | 16 | PF00653 | 0.474 |
LIG_BRCT_BRCA1_1 | 94 | 98 | PF00533 | 0.400 |
LIG_DLG_GKlike_1 | 119 | 127 | PF00625 | 0.500 |
LIG_FHA_1 | 128 | 134 | PF00498 | 0.497 |
LIG_FHA_1 | 31 | 37 | PF00498 | 0.350 |
LIG_LIR_Apic_2 | 81 | 85 | PF02991 | 0.452 |
LIG_LIR_Gen_1 | 116 | 123 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 116 | 120 | PF02991 | 0.335 |
LIG_LIR_Nem_3 | 196 | 202 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 218 | 223 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 51 | 55 | PF02991 | 0.453 |
LIG_LIR_Nem_3 | 99 | 105 | PF02991 | 0.519 |
LIG_Pex14_2 | 98 | 102 | PF04695 | 0.452 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.402 |
LIG_SH2_CRK | 82 | 86 | PF00017 | 0.452 |
LIG_SH2_GRB2like | 82 | 85 | PF00017 | 0.452 |
LIG_SH2_SRC | 82 | 85 | PF00017 | 0.452 |
LIG_SH2_STAT5 | 105 | 108 | PF00017 | 0.429 |
LIG_SH2_STAT5 | 168 | 171 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 199 | 202 | PF00017 | 0.409 |
LIG_SH2_STAT5 | 208 | 211 | PF00017 | 0.391 |
LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.436 |
LIG_SUMO_SIM_par_1 | 148 | 154 | PF11976 | 0.418 |
LIG_SUMO_SIM_par_1 | 225 | 231 | PF11976 | 0.281 |
LIG_SUMO_SIM_par_1 | 83 | 90 | PF11976 | 0.411 |
LIG_UBA3_1 | 86 | 93 | PF00899 | 0.403 |
MOD_CK1_1 | 122 | 128 | PF00069 | 0.514 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.428 |
MOD_CK1_1 | 177 | 183 | PF00069 | 0.333 |
MOD_CK1_1 | 63 | 69 | PF00069 | 0.438 |
MOD_CK2_1 | 62 | 68 | PF00069 | 0.567 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.271 |
MOD_GlcNHglycan | 157 | 160 | PF01048 | 0.229 |
MOD_GlcNHglycan | 27 | 30 | PF01048 | 0.401 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.470 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.504 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.400 |
MOD_NEK2_1 | 44 | 49 | PF00069 | 0.448 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.400 |
MOD_NEK2_2 | 3 | 8 | PF00069 | 0.343 |
MOD_Plk_1 | 232 | 238 | PF00069 | 0.411 |
MOD_Plk_4 | 177 | 183 | PF00069 | 0.433 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.401 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.584 |
TRG_DiLeu_BaLyEn_6 | 82 | 87 | PF01217 | 0.429 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.515 |
TRG_ENDOCYTIC_2 | 220 | 223 | PF00928 | 0.273 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.379 |
TRG_Pf-PMV_PEXEL_1 | 104 | 108 | PF00026 | 0.200 |
TRG_Pf-PMV_PEXEL_1 | 163 | 167 | PF00026 | 0.197 |
TRG_PTS1 | 238 | 241 | PF00515 | 0.380 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IHW3 | Leptomonas seymouri | 66% | 100% |
A0A0N1PCR6 | Leptomonas seymouri | 32% | 100% |
A0A1X0NZ20 | Trypanosomatidae | 34% | 100% |
A0A1X0NZ92 | Trypanosomatidae | 57% | 100% |
A0A422N3N7 | Trypanosoma rangeli | 55% | 100% |
A0A422N3S1 | Trypanosoma rangeli | 37% | 100% |
A4HBT6 | Leishmania braziliensis | 34% | 100% |
A4HBT7 | Leishmania braziliensis | 80% | 100% |
A4II60 | Xenopus tropicalis | 32% | 100% |
D0A1D6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
D0A1D7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
D0A1E6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 38% | 100% |
E9AGU6 | Leishmania infantum | 34% | 94% |
E9AGU7 | Leishmania infantum | 100% | 100% |
E9AV58 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 34% | 100% |
E9AV59 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 99% |
O66821 | Aquifex aeolicus (strain VF5) | 33% | 100% |
O69537 | Mycobacterium leprae (strain TN) | 31% | 100% |
P07833 | Plasmodium falciparum (isolate K1 / Thailand) | 29% | 100% |
P09383 | Schistosoma mansoni | 30% | 85% |
P0A5T1 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 31% | 100% |
P0DD40 | Streptococcus pyogenes serotype M3 (strain ATCC BAA-595 / MGAS315) | 34% | 100% |
P0DD41 | Streptococcus pyogenes serotype M3 (strain SSI-1) | 34% | 100% |
P20035 | Plasmodium falciparum (isolate FCR-3 / Gambia) | 29% | 100% |
P37171 | Rhodobacter capsulatus (strain ATCC BAA-309 / NBRC 16581 / SB1003) | 32% | 100% |
P43152 | Leishmania donovani | 34% | 100% |
P45078 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 29% | 100% |
P51900 | Tritrichomonas foetus | 36% | 100% |
P96794 | Mycobacterium avium | 34% | 100% |
P9WHQ8 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 31% | 100% |
P9WHQ9 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 31% | 100% |
Q07010 | Trypanosoma brucei brucei | 39% | 100% |
Q26997 | Toxoplasma gondii | 31% | 100% |
Q27541 | Crithidia fasciculata | 33% | 100% |
Q4QCC2 | Leishmania major | 94% | 99% |
Q4QCC3 | Leishmania major | 33% | 94% |
Q54NJ8 | Dictyostelium discoideum | 28% | 100% |
Q5HRP4 | Staphylococcus epidermidis (strain ATCC 35984 / RP62A) | 28% | 100% |
Q5M216 | Streptococcus thermophilus (strain CNRZ 1066) | 32% | 100% |
Q5M6K8 | Streptococcus thermophilus (strain ATCC BAA-250 / LMG 18311) | 32% | 100% |
Q5XEL6 | Streptococcus pyogenes serotype M6 (strain ATCC BAA-946 / MGAS10394) | 34% | 100% |
Q6DCP3 | Xenopus laevis | 32% | 100% |
Q7CNQ9 | Streptococcus pyogenes serotype M18 (strain MGAS8232) | 34% | 100% |
Q7KLF3 | Leishmania donovani | 34% | 94% |
Q839B2 | Enterococcus faecalis (strain ATCC 700802 / V583) | 33% | 100% |
Q8CQV4 | Staphylococcus epidermidis (strain ATCC 12228 / FDA PCI 1200) | 28% | 100% |
Q8DRP8 | Streptococcus pneumoniae (strain ATCC BAA-255 / R6) | 34% | 100% |
Q8E2H3 | Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) | 35% | 100% |
Q8E7Y1 | Streptococcus agalactiae serotype III (strain NEM316) | 35% | 100% |
Q8K9U8 | Buchnera aphidicola subsp. Schizaphis graminum (strain Sg) | 31% | 100% |
Q97TC4 | Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) | 34% | 100% |
V5DEL0 | Trypanosoma cruzi | 55% | 78% |